Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Health & Fitness
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/a2/d0/2e/a2d02e38-ee60-a2a4-bf5c-e6d951b93b39/mza_3048579604930026653.jpg/600x600bb.jpg
ATTD: Advanced Technologies and Treatments for Diabetes
ATTD on UNLOK
41 episodes
4 days ago
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.
Show more...
Life Sciences
Science
RSS
All content for ATTD: Advanced Technologies and Treatments for Diabetes is the property of ATTD on UNLOK and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/43275051/43275051-1754912012833-ca3306abe8922.jpg
Updates and Emerging Trends in Long-Acting Insulin Therapy
ATTD: Advanced Technologies and Treatments for Diabetes
34 minutes 14 seconds
2 months ago
Updates and Emerging Trends in Long-Acting Insulin Therapy

In today’s episode host Ginger Vieira discusses the latest advancements and emerging trends in long-acting insulin therapy with guest Lucia M. Novak, MSN, ANP-BC, BC-ADM.

They cover:

  • The latest clinical trials and guidelines

  • New insulin formations

  • Smart delivery technologies

  • The potential of GLP-1 and GIP hormones

  • Advice on lowering treatment burden and improving the quality of life for those living with diabetes

Lucia is a board-certified Nurse Practitioner with almost 30 years of clinical expertise in diabetes management. She’s a Consultant, Advisor, National Speaker, Author, Educator, Advocate, and is the President and Founder of Diabesity, LLC.

If you’d like to deepen your knowledge on this topic, why not enroll in the e-Learning course ‘Updates and Emerging Trends in Long-Acting Insulin Therapy’ on the Unlok Education website. Led by esteemed experts Dr. Arthi Thirumalai and Prof. Dr. Eda Cengiz, this session delves into recent clinical trials, updated guidelines, and emerging trends that are shaping the future of diabetes management.

This is an accredited activity that gives you 1 CME/CPD credit.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.